checkAd

     209  0 Kommentare Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress - Seite 3


    Digital Poster* (Available on the Congress app, online platform, and digital poster terminals at the congress venue; Q&A chat box function also available)

    Title: Treatment of Adult Epilepsy Patients with Perampanel: Evidence from Real-World Studies
    Authors: Adam Strzelczyk, Eric Segal, Tim Wehner, Leock Y Ngo, Ricardo Sainz Fuertes, Mar Carreño, Tony Wu, Bernhard J. Steinhoff, Vicente Villanueva
    Poster number: P373
    Digital Poster* Session and Rapid-Fire Presentation Name:  Drug Therapy 4
    Rapid Fire Presentation (2-minute session):
    Time and Date: Monday, September 4, 2023, at 2:00 PM-2:30 PM BST
    Location: Digital Poster Station: Level 3 Foyer - Station C

    Title: Study 512 Design: Perampanel as First Adjunctive Therapy in Patients Aged ≥12 Years with Focal-Onset Seizures or Generalised Tonic-Clonic Seizures Associated With Genetic Generalised Epilepsy
    Authors: Sergey Burd, Giovanni Assenza, Sofia Quintas, Francisco José Gil López, Jan Wagner, Anna Patten, Ricardo Sáinz-Fuertes, Stanislas Lagarde, Tobias Sejbaek, Pavel Vlasov, Vadim Kharkovskiy, Anna Lebedeva
    Poster number: P505
    Digital Poster* (Available on the Congress app, online platform, and digital poster terminals at the congress venue; Q&A chat box function also available)

    Title: PERPRISE (PERampanel in patients with PRImary or SEcondarily generalised seizures): First Interim Analysis of the Observational Study Assessing Perampanel as the Only Adjunctive Therapy
    Authors: Bernhard J Steinhoff, Tobias Goldmann, Yaroslav Winter
    Poster number: P534
    Digital Poster* (Available on the Congress app, online platform, and digital poster terminals at the congress venue; Q&A chat box function also available)

    Title: Outcomes by Seizure Type from A Mirroring Clinical Practice Study of Perampanel in Adults and Adolescents (AMPA)
    Authors: Sara Casciato, Martina Chiacchiaretta, Paola Mansi, Ricardo Sáinz-Fuertes, Anna Patten, Anna Gentile
    Poster number: P529
    Digital Poster* (Available on the Congress app, online platform, and digital poster terminals at the congress venue; Q&A chat box function also available)

    Title: ELEVATE Study 410: Analysis of Time to First Seizure with Perampanel as Monotherapy or First Adjunctive Therapy in Patients with Focal-Onset Seizures or Generalised Tonic-Clonic Seizures
    Authors: Pavel Klein, Omar Samad, Leock Y Ngo, Dinesh Kumar, Manoj Malhotra
    Poster number: P540
    Digital Poster* (Available on the Congress app, online platform, and digital poster terminals at the congress venue; Q&A chat box function also available)

    Seite 3 von 7



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress - Seite 3 CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel …